Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
- Soldier hacked to death in London in suspected Islamist attack
- FBI says man shot dead while being questioned about Boston bombings
- Short story writer Lydia Davis wins Man Booker International fiction prize
- Sreesanth says did not indulge in spot-fixing
- Daiichi Sankyo says it was misled over Ranbaxy probes
REUTERS SHOWCASE
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Economic Survey: FY13 fiscal deficit seen at 4.1 pct of GDP
NEW DELHI |
NEW DELHI (Reuters) - India's fiscal deficit is likely to narrow to 4.1 percent of the gross domestic product in the fiscal year that starts on April 1, a finance ministry report said on Thursday.
New Delhi is widely expected to miss this fiscal year's deficit target of 4.6 percent of GDP by a wide margin on account of a hefty subsidy bill and sluggish tax receipts.
The report said the deficit was expected to further narrow to 3.5 percent in the fiscal year that begins in April 2013.
(Reporting by Manoj Kumar and Krittivas Mukherjee; editing by Malini Menon)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints






Follow Reuters